DRUGS FIVE YEARS LATER - CYTARABINE

被引：81

作者：

KREMER, WB

机构：

[1] VET ADM HOSP, DEPT MED, DURHAM, NC 27705 USA

[2] DUKE UNIV, COMPREHENS CANC CTR, DURHAM, NC USA

来源：

关键词：

D O I：

10.7326/0003-4819-82-5-684

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：684 / 688

页数：5

共 51 条

[1] BAND PR, 1973, CANCER, V32, P744, DOI 10.1002/1097-0142(197310)32:4<744::AID-CNCR2820320402>3.0.CO
[2] 2-J
[3] CYTOGENETIC AND MORPHOLOGIC ABNORMALITIES IN HUMAN BONE MARROW CELLS DURING CYTOSINE ARABINOSIDE THERAPY
BELL, WR
WHANG, JJ
CARBONE, PP
BRECHER, G
BLOCK, JB
[J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1966, 27 (06): : 771 - +
[4] BENEDICT WF, 1970, CANCER RES, V30, P2477
[5] BERNARD J, 1972, SEMIN HEMATOL, V9, P181
[6] BHUYAN BK, 1972, CANCER RES, V32, P398
[7] BODEY GP, 1969, CANCER CHEMOTH REP 1, V53, P59
[8] STUDIES OF ENZYMATIC DEAMINATION OF CYTOSINE ARABINOSIDE .1. ENZYME DISTRIBUTION AND SPECIES SPECIFICITY
CAMIENER, GW
SMITH, CG
[J]. BIOCHEMICAL PHARMACOLOGY, 1965, 14 (10) : 1405 - &
[9] CHU MY, 1968, BIOCHEM PHARMACOL, V17, P753
[10] COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE
CHU, MY
FISCHER, GA
[J]. BIOCHEMICAL PHARMACOLOGY, 1965, 14 (03) : 333 - +